Interview with: Eric Henderson, Ph.D., Founder, Chairman & CSO - featuring: their NanoArrayer™, which is a printing machine or a surface modifying machine that allows one to put molecules and materials onto silicon chips or other surfaces, with extremely high precision to provide a pathway for building ultra miniaturized devices and bioanalytical tests.

BioForce Nanosciences, Inc. (BFNH-OTC: BB)

CURRENT ISSUE  |  COVER ARCHIVES  |   INDEX   |   CONTACT   |   FINANCIALS   |  MARKETING SERVICES  |  HOME PAGE

CEOCFO-Members Login
Become A Member!

This is a printer friendly page!

BioForce Nanosciences could be one of the founding fathers of nanotechnology building on their NanoArrayer instrumentation



Healthcare
Nanotechnology
(BFNH-OTC: BB)

BioForce Nanosciences, Inc.




Eric Henderson, Ph.D.
Founder, Chairman & CSO

Interview conducted by:
Lynn Fosse, Senior Editor
CEOCFOinterviews.com
July 20, 2006

disclaimers

Any reproduction or further distribution of this article without the express written consent of CEOCFOinterviews.com is prohibited.

“In the long run, assuming we can stay on track and achieve our projected break-even point, we are well positioned to be one of a few founding companies in this industry. Moreover, by feeding in new technologies at the appropriate times, we should be able to maintain that stature. I often think in terms of models provided by long-lived Japanese and European companies that, after a hundred or more years of evolution, end up manufacturing chemicals, making electronic devices and also operating a food production component. I would like this company to be one of the founding fathers of nanotechnology, and how we diversify over time will be both exciting and somewhat unpredictable. We could end up being the primary producer of home health products, proteins and petroleum!” - Eric Henderson, Ph.D.